{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:07:57Z","timestamp":1780380477312,"version":"3.54.1"},"reference-count":50,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Dermatomyositis is a rare autoimmune inflammatory condition affecting skin and muscles. The disease can be seen in both adults and children. It can be associated with malignancy. Considering involvement of skin in the disease, many patients consult dermatologists for its treatment. Hence, knowledge about its presentation, complications, prognosis, and treatment is necessary.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of this review article is to provide comprehensive information about treatment of dermatomyositis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this review article, we reviewed the published literature on adult and juvenile dermatomyositis to highlight the treatment. Articles published in peer\u2010reviewed journals including reviews, clinical trials, case series, and case reports published in electronic database (MEDLINE\/PubMed) through January 2021, cross references of respective articles and trials from <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\">clinicaltrials.gov<\/jats:ext-link> were included for qualitative analysis of the literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Treatment options for dermatomyositis include traditional immunosuppressive agents and immunomodulatory therapy. High\u2010dose corticosteroids represent the first line of treatment while other immunosuppressive agents are also used, either in combination with or as an alternative to corticosteroids, after initial treatment failure. Some biological agents have been used for the treatment of dermatomyositis with variable responses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although several treatment options are available, several questions remain unanswered about the optimal treatment of dermatomyositis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jocd.15363","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:04:01Z","timestamp":1662451441000},"page":"395-401","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Adult and juvenile dermatomyositis treatment"],"prefix":"10.1111","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9455-4025","authenticated-orcid":false,"given":"Anant","family":"Patil","sequence":"first","affiliation":[{"name":"Department of Pharmacology Dr. DY Patil Medical College  Navi Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[{"name":"UConn Health Department of Dermatology  Farmington Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kassir","sequence":"additional","affiliation":[{"name":"Worldwide laser institute  Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Babaei","sequence":"additional","affiliation":[{"name":"Shahid Beheshti University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8646-1179","authenticated-orcid":false,"given":"Mohamad","family":"Goldust","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Medical Center of the Johannes Gutenberg University  Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"e_1_2_19_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1467257"},{"key":"e_1_2_19_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1403549"},{"key":"e_1_2_19_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00502-6"},{"key":"e_1_2_19_5_1","first-page":"44","article-title":"Polymyositis\/dermatomyositis \u2013 clinical picture and treatment","volume":"59","author":"Anic B","year":"2012","journal-title":"Reumatizam"},{"key":"e_1_2_19_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-018-0037-5"},{"key":"e_1_2_19_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2014.02.006"},{"key":"e_1_2_19_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.139"},{"key":"e_1_2_19_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14726"},{"key":"e_1_2_19_10_1","first-page":"211","article-title":"Update on the treatment of calcinosis in dermatomyositis","volume":"53","author":"Shinjo SK","year":"2013","journal-title":"Rev Bras Rheumatol"},{"key":"e_1_2_19_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-017-0058-1"},{"key":"e_1_2_19_12_1","first-page":"1073","article-title":"How can we effectively address the paraneoplastic dermatomyositis: diagnosis, risk factors and treatment options","volume":"22","author":"Zerdes I","year":"2017","journal-title":"J BUON"},{"key":"e_1_2_19_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2008.09.004"},{"key":"e_1_2_19_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.105"},{"issue":"8","key":"e_1_2_19_15_1","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","volume":"2012","author":"Gordon PA","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_19_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-018-0565-8"},{"key":"e_1_2_19_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14445"},{"key":"e_1_2_19_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.1.7"},{"key":"e_1_2_19_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236431"},{"key":"e_1_2_19_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.023"},{"key":"e_1_2_19_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37754"},{"key":"e_1_2_19_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew396"},{"key":"e_1_2_19_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-017-0327-z"},{"key":"e_1_2_19_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211751"},{"key":"e_1_2_19_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12732"},{"key":"e_1_2_19_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.03.003"},{"key":"e_1_2_19_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000984"},{"key":"e_1_2_19_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14276"},{"key":"e_1_2_19_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.0866"},{"key":"e_1_2_19_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.10.010"},{"key":"e_1_2_19_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.11.019"},{"key":"e_1_2_19_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000999"},{"key":"e_1_2_19_33_1","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S231667"},{"key":"e_1_2_19_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12308"},{"key":"e_1_2_19_35_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9163201"},{"key":"e_1_2_19_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0974-5"},{"key":"e_1_2_19_37_1","article-title":"Low\u2010dose naltrexone: a unique treatment for amyopathic dermatomyositis","volume":"35","author":"Manudhane AP","year":"2019","journal-title":"Dermatol Online J"},{"key":"e_1_2_19_38_1","first-page":"904","article-title":"Interleukin\u20101 receptor antagonist for refractory anti\u2010MDA5 clinically amyopathic dermatomyopathy","volume":"33","author":"Groh M","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_19_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-019-00313-8"},{"key":"e_1_2_19_40_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160688"},{"key":"e_1_2_19_41_1","first-page":"299","article-title":"Juvenile dermatomyositis: review and update of the pathogenesis and treatment","volume":"50","author":"Neto NSR","year":"2010","journal-title":"Rev Bras Rheumatol"},{"key":"e_1_2_19_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0134-0"},{"key":"e_1_2_19_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-017-0240-6"},{"key":"e_1_2_19_44_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190494"},{"key":"e_1_2_19_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40418"},{"key":"e_1_2_19_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-017-0174-0"},{"key":"e_1_2_19_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000430"},{"key":"e_1_2_19_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000538"},{"key":"e_1_2_19_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-017-0199-4"},{"key":"e_1_2_19_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41236"},{"key":"e_1_2_19_51_1","first-page":"410","article-title":"Dermatomyositis and polymyositis: new treatment targets on the horizon","volume":"69","author":"Hak AE","year":"2011","journal-title":"Neth J Med"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.15363","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jocd.15363","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.15363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T06:07:16Z","timestamp":1717654036000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jocd.15363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1111\/jocd.15363"],"URL":"https:\/\/doi.org\/10.1111\/jocd.15363","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"2022-06-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}